On September 30, 2025, Assort Health, a comprehensive patient experience platform powered by specialty-specific agentic AI, announced the close of a $76 million Series B financing round led by Lightspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet. A Wilson Sonsini Goodrich & Rosati team led by Lang Liu, Alex Youssef, and Andrew Lu advised Assort Health on the transaction.

Assort Health addresses common challenges in scheduling medical appointments, such as long wait times and inefficient communication. The company has raised $102 million to date and plans to use these funds to expand the team and accelerate the development of a comprehensive, proprietary platform—Assort OS.

The Wilson Sonsini Corporate team that advised Assort Health on the transaction also includes Colin Conklin, Jing Zhang, and Madisyn Klein.

For more information, please see Assort Health's news release. Additional coverage can be found on Fortune.